• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MUC16的膜近端胞外结构域切割发生在酸性高尔基体/高尔基体后区室中。

Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments.

作者信息

Das Srustidhar, Majhi Prabin D, Al-Mugotir Mona H, Rachagani Satyanarayana, Sorgen Paul, Batra Surinder K

机构信息

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.

1] Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA [2] Department of Pathology, University of Nebraska Medical Center, Omaha, NE 68198, USA [3] Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

Sci Rep. 2015 Jun 5;5:9759. doi: 10.1038/srep09759.

DOI:10.1038/srep09759
PMID:26044153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4456727/
Abstract

MUC16, precursor of the most widely used ovarian cancer biomarker CA125, is up regulated in multiple malignancies and is associated with poor prognosis. While the pro-tumorigenic and metastatic roles of MUC16 are ascribed to the cell-associated carboxyl-terminal MUC16 (MUC16-Cter), the exact biochemical nature of MUC16 cleavage generating MUC16-Cter has remained unknown. Using different lengths of dual-epitope (N-terminal FLAG- and C-terminal HA-Tag) tagged C-terminal MUC16 fragments, we demonstrate that MUC16 cleavage takes place in the juxta-membrane ectodomain stretch of twelve amino acids that generates a ~17 kDa cleaved product and is distinct from the predicted sites. This was further corroborated by domain swapping experiment. Further, the cleavage of MUC16 was found to take place in the Golgi/post-Golgi compartments and is dependent on the acidic pH in the secretory pathway. A similar pattern of ~17 kDa cleaved MUC16 was observed in multiple cell types eliminating the possibility of cell type specific phenomenon. MUC16-Cter translocates to the nucleus in a cleavage dependent manner and binds to the chromatin suggesting its involvement in regulation of gene expression. Taken together, we demonstrate for the first time the oft-predicted cleavage of MUC16 that is critical in designing successful therapeutic interventions based on MUC16.

摘要

MUC16是最常用的卵巢癌生物标志物CA125的前体,在多种恶性肿瘤中上调,且与预后不良相关。虽然MUC16的促肿瘤发生和转移作用归因于细胞相关的羧基末端MUC16(MUC16-Cter),但产生MUC16-Cter的MUC16裂解的确切生化性质仍不清楚。使用不同长度的双表位(N端FLAG和C端HA标签)标记的C端MUC16片段,我们证明MUC16裂解发生在由12个氨基酸组成的近膜胞外区域,产生一个约17 kDa的裂解产物,且与预测位点不同。结构域交换实验进一步证实了这一点。此外,发现MUC16的裂解发生在高尔基体/高尔基体后区室,并且依赖于分泌途径中的酸性pH。在多种细胞类型中观察到类似的约17 kDa的裂解MUC16模式,排除了细胞类型特异性现象的可能性。MUC16-Cter以裂解依赖的方式转运到细胞核并与染色质结合,表明其参与基因表达调控。综上所述,我们首次证明了MUC16的裂解,这对于基于MUC16设计成功的治疗干预措施至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/c180c150f676/srep09759-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/9837722381b0/srep09759-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/1b88bef78ecd/srep09759-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/85d75b68704c/srep09759-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/4cd675926eb2/srep09759-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/b14bafd82219/srep09759-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/c180c150f676/srep09759-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/9837722381b0/srep09759-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/1b88bef78ecd/srep09759-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/85d75b68704c/srep09759-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/4cd675926eb2/srep09759-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/b14bafd82219/srep09759-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0076/4456727/c180c150f676/srep09759-f6.jpg

相似文献

1
Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments.MUC16的膜近端胞外结构域切割发生在酸性高尔基体/高尔基体后区室中。
Sci Rep. 2015 Jun 5;5:9759. doi: 10.1038/srep09759.
2
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.MUC16的羧基末端结构域通过JAK2向胰腺癌细胞的核转位赋予致瘤和转移功能。
Oncotarget. 2015 Mar 20;6(8):5772-87. doi: 10.18632/oncotarget.3308.
3
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.MUC16/CA125羧基末端部分的表达诱导细胞转化和肿瘤侵袭。
PLoS One. 2015 May 12;10(5):e0126633. doi: 10.1371/journal.pone.0126633. eCollection 2015.
4
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.针对特定MUC16糖基化位点的抗体可抑制卵巢癌生长。
ACS Chem Biol. 2017 Aug 18;12(8):2085-2096. doi: 10.1021/acschembio.7b00305. Epub 2017 Jun 28.
5
Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.卵巢癌患者腹水通过 Akt 依赖性途径刺激人腹膜间皮细胞中 MUC16 粘蛋白的表达和分泌。
BMC Cancer. 2019 Apr 30;19(1):406. doi: 10.1186/s12885-019-5611-7.
6
Structural basis for antibody recognition of the proximal MUC16 ectodomain.近端MUC16胞外域抗体识别的结构基础。
J Ovarian Res. 2024 Feb 19;17(1):41. doi: 10.1186/s13048-024-01373-9.
7
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies.展示外部、膜相邻 MUC16 表位的病毒样颗粒疫苗可引发卵巢癌反应性抗体。
J Ovarian Res. 2024 Jan 16;17(1):19. doi: 10.1186/s13048-023-01325-9.
8
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.用于理解人卵巢癌中 MUC16 裂解的羧基末端特异性单克隆抗体的开发和鉴定。
PLoS One. 2018 Apr 30;13(4):e0193907. doi: 10.1371/journal.pone.0193907. eCollection 2018.
9
The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.MUC16(CA125)在卵巢细胞转化和肿瘤进展中的作用演变。
Carcinogenesis. 2021 Apr 17;42(3):327-343. doi: 10.1093/carcin/bgab010.
10
Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.针对MUC16近端(羧基末端)部分的新型单克隆抗体。
Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):462-72. doi: 10.1097/PAI.0b013e3181dbfcd2.

引用本文的文献

1
The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review.黏蛋白在癌症及癌症进展中的作用:综述
Curr Issues Mol Biol. 2025 May 29;47(6):406. doi: 10.3390/cimb47060406.
2
The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden.循环糖类抗原125对ST2及长期复发疾病负担的调节作用。
Sci Rep. 2025 Jan 14;15(1):1905. doi: 10.1038/s41598-024-84622-7.
3
Structural basis for antibody recognition of the proximal MUC16 ectodomain.近端MUC16胞外域抗体识别的结构基础。

本文引用的文献

1
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.MUC16的羧基末端结构域通过JAK2向胰腺癌细胞的核转位赋予致瘤和转移功能。
Oncotarget. 2015 Mar 20;6(8):5772-87. doi: 10.18632/oncotarget.3308.
2
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.MUC16(CA125):癌症治疗的肿瘤生物标志物,一项正在进行的工作。
Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129.
3
MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression.
J Ovarian Res. 2024 Feb 19;17(1):41. doi: 10.1186/s13048-024-01373-9.
4
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies.展示外部、膜相邻 MUC16 表位的病毒样颗粒疫苗可引发卵巢癌反应性抗体。
J Ovarian Res. 2024 Jan 16;17(1):19. doi: 10.1186/s13048-023-01325-9.
5
Role of Macrophage Colony-Stimulating Factor for Staphylococcal Infection in the Oral Cavity.巨噬细胞集落刺激因子在口腔葡萄球菌感染中的作用
J Clin Med. 2023 Sep 7;12(18):5825. doi: 10.3390/jcm12185825.
6
Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors.血浆小非编码 RNA 作为孕激素受体阴性型浆液性卵巢肿瘤的诊断分子。
Int J Mol Sci. 2023 Jul 30;24(15):12214. doi: 10.3390/ijms241512214.
7
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies.靶向癌黏蛋白16上独特表位的嵌合抗体可减轻胰腺和肺部恶性肿瘤的肿瘤负担。
NPJ Precis Oncol. 2023 Aug 11;7(1):74. doi: 10.1038/s41698-023-00423-7.
8
Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer.循环和非循环蛋白质及核酸作为卵巢癌的生物标志物和治疗分子
Genes Dis. 2022 Aug 5;10(3):1005-1018. doi: 10.1016/j.gendis.2022.07.004. eCollection 2023 May.
9
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers.靶抗原特性及其对血液系统恶性肿瘤和实体瘤中临床批准的抗体药物偶联物(ADC)的贡献
Cancers (Basel). 2023 Mar 19;15(6):1845. doi: 10.3390/cancers15061845.
10
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.Muc16 耗竭通过改变胰腺导管腺癌中的肿瘤微环境因子来减弱 KRAS 诱导的肿瘤发生和转移。
Oncogene. 2022 Nov;41(48):5147-5159. doi: 10.1038/s41388-022-02493-6. Epub 2022 Oct 21.
粘蛋白16(MUC16,即癌抗原125)通过降低肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体R2的表达并增加细胞凋亡抑制蛋白(c-FLIP)的表达来减弱TRAIL诱导的细胞凋亡。
BMC Cancer. 2014 Apr 1;14:234. doi: 10.1186/1471-2407-14-234.
4
Somatic mutaome profile in human cancer tissues.人类癌组织中的体细胞突变图谱
Genomics Inform. 2013 Dec;11(4):239-44. doi: 10.5808/GI.2013.11.4.239. Epub 2013 Dec 31.
5
CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.CA125/MUC16 与 Src 家族激酶相互作用,其 C 端片段在人上皮癌细胞中的过度表达降低细胞间黏附。
Eur J Cell Biol. 2013 Aug-Sep;92(8-9):257-63. doi: 10.1016/j.ejcb.2013.10.005. Epub 2013 Oct 26.
6
Molecular mechanism and functional role of brefeldin A-mediated ADP-ribosylation of CtBP1/BARS.布雷菲德菌素 A 介导 CtBP1/BARS 的 ADP-核糖基化的分子机制和功能作用。
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9794-9. doi: 10.1073/pnas.1222413110. Epub 2013 May 28.
7
Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.阿柏西利作为上皮性卵巢癌维持治疗的 III 期临床试验:AGO OVAR、COGI、GINECO 和 GEICO——MIMOSA 研究。
J Clin Oncol. 2013 Apr 20;31(12):1554-61. doi: 10.1200/JCO.2012.46.4057. Epub 2013 Mar 11.
8
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.黏蛋白 16(癌抗原 125)在人组织和细胞系中的表达及其与胰腺、食管、胃和结肠腺癌临床结局的相关性。
Hum Pathol. 2012 Oct;43(10):1755-63. doi: 10.1016/j.humpath.2012.01.005. Epub 2012 Apr 26.
9
A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier.肺炎链球菌分泌的一种金属蛋白酶从上皮细胞糖萼屏障中去除膜粘蛋白 MUC16。
PLoS One. 2012;7(3):e32418. doi: 10.1371/journal.pone.0032418. Epub 2012 Mar 7.
10
Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.MUC16 和间皮素的共表达与胰腺导管腺癌的浸润过程有关。
Cancer Sci. 2012 Apr;103(4):739-46. doi: 10.1111/j.1349-7006.2012.02214.x. Epub 2012 Feb 23.